Characterization and Prognostic Value of Mutations in Exons 5 and 6 of the p53 Gene in Patients with Colorectal Cancers in Central Iran
2
조회
0
다운로드
0
인용
0
참고문헌
초록
Background/Aims: We aimed to investigate the relationships among various mutations of the p53 gene and their protein products, histological characteristics, and disease prognosis of primary colorectal cancer in Isfahan, central Iran. Methods: Sixty-one patients with colorectal adenocarcinoma were enrolled in the study. Mutations of the p53gene were detected by single-stranded conformation polymorphism and DNA sequencing. The protein stability was evaluated by immunohistochemistry. Patients were followed up to 48 months. Results: Twenty-one point mutations in exons 5 and 6 were detected in the tumor specimens of 14patients (23%). Of those, 81% and 9.5% were missense and nonsense mutations, respectively. There were also two novel mutations in the intronic region between exons 5 and 6. In 11 mutated specimens, protein stability and protein accumulation were identified. There was a relationship between the type of mutation and protein accumulation in exons 5 and 6of the p53 gene. The presence of the mutation was associated with an advanced stage of cancer (trend, p<0.009). Patients with mutated p53 genes had significantly lower survival rates than those with wild type p53 genes (p<0.01). Conclusions: Mutations in exons 5 and 6 of the p53 gene are common genetic alterations in colorectal adenocarcinoma in central Iran and are associated with a poor prognosis of the disease.
Abstract
Background/Aims: We aimed to investigate the relationships among various mutations of the p53 gene and their protein products, histological characteristics, and disease prognosis of primary colorectal cancer in Isfahan, central Iran. Methods: Sixty-one patients with colorectal adenocarcinoma were enrolled in the study. Mutations of the p53gene were detected by single-stranded conformation polymorphism and DNA sequencing. The protein stability was evaluated by immunohistochemistry. Patients were followed up to 48 months. Results: Twenty-one point mutations in exons 5 and 6 were detected in the tumor specimens of 14patients (23%). Of those, 81% and 9.5% were missense and nonsense mutations, respectively. There were also two novel mutations in the intronic region between exons 5 and 6. In 11 mutated specimens, protein stability and protein accumulation were identified. There was a relationship between the type of mutation and protein accumulation in exons 5 and 6of the p53 gene. The presence of the mutation was associated with an advanced stage of cancer (trend, p<0.009). Patients with mutated p53 genes had significantly lower survival rates than those with wild type p53 genes (p<0.01). Conclusions: Mutations in exons 5 and 6 of the p53 gene are common genetic alterations in colorectal adenocarcinoma in central Iran and are associated with a poor prognosis of the disease.
참고문헌 (42)
- Karsa LV, "The dimensions of the CRC problem", Best Pract Res Clin Gastroenterol, 24, pp.381~396 (2010)
- Jemal A, "Global patterns of cancer incidence and mortality rates and trends", Cancer Epidemiol Biomarkers Prev, 19, pp.1893~1907 (2010)
- Yee YK, "Epidemiology of colorectal cancer in Asia", J Gastroenterol Hepatol, 24, pp.1810~1816 (2009)
- Sadjadi A, "Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran", Int J Cancer, 107, pp.113~118 (2003)
- Markowitz SD, "Molecular origins of cancer: molecular basis of colorectal cancer", N Engl J Med, 361, pp.2449~2460 (2009)
- Cunningham D, "Colorectal cancer", Lancet, 375, pp.1030~1047 (2010)
- Gryfe R, "Overview of colorectal cancer genetics", Surg Oncol Clin N Am, 18, pp.573~583 (2009)
- Russo A, "The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment", J Clin Oncol, 23, pp.7518~7528 (2005)
- Carson DA, "Cancer progression and p53", Lancet, 346, pp.1009~1011 (1995)
- Rogel A, "p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors", Mol Cell Biol, 5, pp.2851~2855 (1985)
- Vogelstein B, "Surfing the p53 network", Nature, 408, pp.307~310 (2000)
- Ryan KM, "Regulation and function of the p53 tumor suppressor protein", Curr Opin Cell Biol, 13, pp.332~337 (2001)
- Schmitt CA, "Apoptosis and chemoresistance in transgenic cancer models", J Mol Med (Berl), 80, pp.137~146 (2002)
- Levine AJ, "The P53 pathway: what questions remain to be explored?", Cell Death Differ, 13, pp.1027~1036 (2006)
- Zhao R, "Analysis of p53-regulated gene expression patterns using oligonucleotide arrays", Genes Dev, 14, pp.981~993 (2000)
- Yamashita K, "Novel method for simultaneous analysis of p53 and K-ras mutations and p53 protein expression in single histologic sections", Arch Pathol Lab Med, 125, pp.347~352 (2001)
- Diez M, "Time-dependency of the prognostic effect of carcinoembryonic antigen and p53 protein in colorectal adenocarcinoma", Cancer, 88, pp.35~41 (2000)
- Chang SC, "Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma", Int J Oncol, 26, pp.65~75 (2005)
- Lam AK, "hTERT expression in colorectal adenocarcinoma: correlations with p21, p53 expressions and clinicopathological features", Int J Colorectal Dis, 23, pp.587~594 (2008)
- Nunes BL, "Metalloproteinase-1, metalloproteinase-7, and p53 immunoexpression and their correlation with clinicopathological prognostic factors in colorectal adenocarcinoma", Int J Biol Markers, 24, pp.156~164 (2009)
- Hollstein M, "p53 mutations in human cancers", Science, 253, pp.49~53 (1991)
- Mahdavinia M, "P53 mutations in colorectal cancer from northern Iran: relationships with site of tumor origin, microsatellite instability and K-ras mutations", J Cell Physiol, 216, pp.543~550 (2008)
- Nasierowska-Guttmejer A, "p53 protein accumulation and p53 gene mutation in colorectal cancer", Pathol Oncol Res, 6, pp.275~279 (2000)
- Pan ZZ, "Co-mutation of p53, K-ras genes and accumulation of p53 protein and its correlation to clinicopathological features in rectal cancer", World J Gastroenterol, 10, pp.3688~3690 (2004)
- Tang R, "Mutations of p53 gene in human colorectal cancer: distinct frameshifts among populations", Int J Cancer, 91, pp.863~868 (2001)
- Munro AJ, "P53 abnormalities and outcomes in colorectal cancer: a systematic review", Br J Cancer, 92, pp.434~444 (2005)
- Tominaga T, "Combination of p53 codon 72 polymorphism and inactive p53 mutation predicts chemosensitivity to 5-fluorouracil in colorectal cancer", Int J Cancer, 126, pp.1691~1701 (2010)
- Zhang SQ, "Hangzhou colorectal cancer staging (modified Duke’s classification)", Chin Med J (Engl), 96, pp.675~680 (1983)
- Leahy DT, "Prognostic significance of p53 abnormalities in colorectal carcinoma detected by PCR-SSCP and immunohistochemical analysis", J Pathol, 180, pp.364~370 (1996)
- Coombs NJ, "Optimisation of DNA and RNA extraction from archival formalin-fixed tissue", Nucleic Acids Res, 27, pp.e12~ (1999)
- Erster S, "Mutational analysis of p53 in human tumors: direct DNA sequencing and SSCP", Methods Mol Biol, 234, pp.219~230 (2003)
- Mousavi SM, "Cancer incidence and mortality in Iran", Ann Oncol, 20, pp.556~563 (2009)
- Bazan V, "Have p53 gene mutations and protein expression a different biological significance in colorectal cancer?", J Cell Physiol, 191, pp.237~246 (2002)
- Kato S, "Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis", Proc Natl Acad Sci U S A, 100, pp.8424~8429 (2003)
- Slattery ML, "A comparison of colon and rectal somatic DNA alterations", Dis Colon Rectum, 52, pp.1304~1311 (2009)
- Derakhshan MH, "Oesophageal and gastric intestinal-type adenocarcinomas show the same male predominance due to a 17 year delayed development in females", Gut, 58, pp.16~23 (2009)
- Lim SC, "Prognostic significance of cyclooxygenase-2 expression and nuclear p53 accumulation in patients with colorectal cancer", J Surg Oncol, 97, pp.51~56 (2008)
- Mollevi DG, "Mutations in TP53 are a prognostic factor in colorectal hepatic metastases undergoing surgical resection", Carcinogenesis, 28, pp.1241~1246 (2007)
- Chang SC, "Relationship between genetic alterations and prognosis in sporadic colorectal cancer", Int J Cancer, 118, pp.1721~1727 (2006)
- Theodoropoulos GE, "P53 and EGFR expression in colorectal cancer: a reappraisal of ‘old’ tissue markers in patients with long follow-up", Anticancer Res, 29, pp.785~791 (2009)
- Anwar S, "Systematic review of genetic influences on the prognosis of colorectal cancer", Br J Surg, 91, pp.1275~1291 (2004)
- Duffy MJ, "Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use", Eur J Cancer, 43, pp.1348~1360 (2007)